Showing results (171-180 of 514) with videos related to

Sort By:
Pageof 52
Journal of Inorganic Biochemistry|January 8, 2008
Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of actionAngela Casini, Christian Hartinger, Chiara Gabbiani, et al.
Food Research International (Ottawa, Ont.)|January 1, 2024
Food proteins from yeast-based precision fermentation: Simple purification of recombinant β-lactoglobulin using polyphosphateL J G Hoppenreijs, A Annibal, G J C Vreeke, et al.
Journal of Inorganic Biochemistry|October 6, 2012
Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cellsGerhard Mühlgassner, Caroline Bartel, Wolfgang F Schmid, et al.
Journal of Analytical Atomic Spectrometry|June 23, 2012
Development of an experimental protocol for uptake studies of metal compounds in adherent tumor cellsAlexander E Egger, Christina Rappel, Michael A Jakupec, et al.
Plant Physiology and Biochemistry : PPB|May 12, 2023
Enhanced edible plant production using nano-manganese and nano-iron fertilizers: Current status, detection methods and risk assessmentAleksandra Szuplewska, Jacek Sikorski, Magdalena Matczuk, et al.
Metallomics : Integrated Biometal Science|February 4, 2017
Application of imaging mass spectrometry approaches to facilitate metal-based anticancer drug researchRonald F S Lee, Sarah Theiner, Anders Meibom, et al.
Inorganic Chemistry|October 29, 2010
Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligandsMichael F Primik, Simone Göschl, Michael A Jakupec, et al.
The Analyst|September 21, 2005
Tumour-inhibiting platinum(II) complexes with aminoalcohol ligands: biologically important transformations studied by micellar electrokinetic chromatography, nuclear magnetic resonance spectroscopy and mass spectrometryPetra Schluga, Christian G Hartinger, Mathea S Galanski, et al.
Journal of Inorganic Biochemistry|April 11, 2006
From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)Christian G Hartinger, Stefanie Zorbas-Seifried, Michael A Jakupec, et al.
Analytical and Bioanalytical Chemistry|August 30, 2018
Critical assessment of different methods for quantitative measurement of metallodrug-protein associationsLuis Galvez, Sarah Theiner, Márkó Grabarics, et al.
Pageof 52